Microsoft vs Nuwellis Inc — how do they compare? Microsoft trades at $397 (market cap $2.99T), while Nuwellis Inc trades at $2.95 (market cap $1.09M). The key difference: Microsoft is far larger — about 2743119.3× Nuwellis Inc's market cap, and Microsoft pays a 0.9% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MSFT | NUWE | |
|---|---|---|
Market Cap | $2.99T | $1.09M |
Volume | 36,654,621 | — |
Sector | Technology | Technology |
52-Week High | $542.07 | $527.46 |
52-Week Low | $352.83 | $2.80 |
Enterprise Value | $2.97T | -$722.58K |
Dividend Yield | 0.9% | — |
Signals from Pluang's Aura AI — not financial advice
Microsoft (MSFT) trades at $397.75, up 1.0% today, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $281.72B in 2025, with net income of $101.83B, and the company has beaten EPS estimates for three consecutive quarters. Analysts maintain an 80.49% buy rating with a consensus price target of $546.70, highlighting AI leadership through Azure and Copilot.
The outlook remains positive given robust earnings growth and AI-driven opportunities, but risks include elevated capital expenditure concerns and competitive pressures. Valuation metrics like a P/E of 23.96 and P/S of 9.43 suggest the stock is fairly priced, supporting a long-term bullish view tempered by near-term volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →